Benefits of oral care on aspiration pneumonia in the elderly Source: Eur Respir J 2002; 20: Suppl. 38, 455s Year: 2002
Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Costs of treatment of hospitalised community-acquired pneumonia from the hospitals’ perspective – a prospective study comparing moxifloxacin with other antibiotic treatment alternatives Source: Eur Respir J 2004; 24: Suppl. 48, 185s Year: 2004
Effectiveness of a physical therapy intervention in patients hospitalized due to community acquired pneumonia Source: International Congress 2016 – Physiotherapy interventions and assessment options in hospitalised patients Year: 2016
Potential economic savings of administration of home intravenous antibiotic therapy to patients with acute respiratory infections in Ireland Source: Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care Year: 2011
Efficacy and safety of levofloxacin treatment of community-acquired pneumonia in hospitalized patients Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005
Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005
Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP Source: Eur Respir J 2013; 41: 123-130 Year: 2013
Oral health care prevents respiratory infection in bed-ridden and tube-feeding patients with recurrent pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 189s Year: 2005
The impact of a stewardship programme on outcomes in patients admitted with community-acquired pneumonia Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020
Assessment of antibiotic prescribing practises for hospitalised patients with suspected sepsis using a score of "likelihood of infection" Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009
The cost of inpatient care in community-acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 258s Year: 2005
Guideline-concordant therapy and outcomes in healthcare-associated pneumonia Source: Eur Respir J 2011; 38: 878-887 Year: 2011
Evaluation of the follow-up of patients with community-acquired pneumonia in a rapid-care pneumological outpatient clinic Source: Eur Respir J 2001; 18: Suppl. 33, 464s Year: 2001
Efficacy and cost analysis of ceftriaxone 1 g versus aminopenicillin-betalactamase inhibitors in the treatment of pneumonia on general medical wards Source: Eur Respir J 2001; 18: Suppl. 33, 137s Year: 2001
Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial Source: Eur Respir J, 58 (2) 2002535; 10.1183/13993003.02535-2020 Year: 2021
Economic evaluation of adherence to treatment guidelines in nonintensive care pneumonia Source: Eur Respir J 2007; 29: 751-756 Year: 2007
The effects of oral care with 0.2% chlorhexidine with toothbrushing to prevent ventilator associated pneumonia in adults' intensive care units Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018
Impact of home hospitalization on treatment compliance in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 207s Year: 2001
Efficacy and safety of extended antithrombotic prophylaxis in elderly medically ill patients Source: Eur Respir J 2017; 49(1): 1601887; DOI: 10.1183/13993003.01887-2016 Year: 2017